This inventor holds 3 USPTO granted patents. Top assignees: Sk Chemicals Co., Ltd., Tiumbio Co., Ltd.. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gyeonggi-do, KR (2015)
- Suwon-si, KR (2013 - 2018)
Company Filing History:
Years Active: 2013-2018
Title: The Innovations of Sang-hwan Kang
Introduction
Sang-hwan Kang is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds and compositions. With a total of 3 patents, his work has the potential to impact various medical treatments.
Latest Patents
One of Sang-hwan Kang's latest patents is focused on 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors. This invention provides a novel 2-pyridyl substituted imidazole derivative, or a pharmaceutically acceptable salt or solvate thereof, which selectively inhibits the transforming growth factor-β (TGF-β) type I receptor (ALK5) and/or the activin type I receptor (ALK4). The patent also includes a pharmaceutical composition comprising this derivative as an active ingredient, along with its use in manufacturing a medicament for preventing or treating diseases mediated by ALK5 and/or ALK4 receptors in mammals. Another significant patent involves a composition for eyelash growth, which relates to a pharmaceutical or cosmetic composition and a method for promoting eyelash growth. This composition utilizes nipradilol or pharmaceutically or cosmetically acceptable salts thereof as active ingredients, and may also include prostaglandin F2α analogs.
Career Highlights
Sang-hwan Kang has worked with reputable companies such as Sk Chemicals Co., Ltd. and Tiumbio Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and product development.
Collaborations
Throughout his career, Sang-hwan Kang has collaborated with notable colleagues, including Keun-Ho Ryu and Bong-Yong Lee. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.
Conclusion
Sang-hwan Kang's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to provide new solutions for various health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile